Results 111 to 120 of about 66,344 (289)

The Correlation between Leukopenia and the Severity of Dengue Hemorrhagic Fever in Pediatric Patients [PDF]

The aim of this study is to investigate the correlation between leukopenia and the severity of DHF in pediatric patients treated at RSPAL dr. Ramelan Surabaya from January 2021 to December 2022.
Sukmana, Judya, Purwoko, Suliman, Mulyadi, Angelina, Anindya, Pramita   +3 more
core   +1 more source

BrECADD in three days: Implementation of a condensed intensive first‐line regimen in Hodgkin lymphoma

British Journal of Haematology, EarlyView.
BrECADD can be delivered over 3 days instead of four, reducing intravenous treatment days by 25% without compromising dose intensity. Among 30 patients with advanced‐stage Hodgkin lymphoma, no unexpected toxicity was observed; there were no early discontinuations, and 1‐year progression‐free and overall survival were both 100%.
Christian Peter Jaworek, Maja Supprian, Paul Jan Bröckelmann, Hishan Tharmaseelan, Justin Ferdinandus, Dennis A. Eichenauer, Anne Sophie Robertz, Janina Jablonski, Vincent Combüchen, Jan‐Oliver Staak, Karin Töpelt, Jan‐Michel Heger, Jon Rischewski, Jannik Stemler, Wolfram Klapper, Peter Borchmann, Bastian von Tresckow   +16 more
wiley   +1 more source

Citopenias secundarias a aloinmunización materna Cytopenias following maternal alloimmunization

Revista Cubana de Hematología, Inmunología y Hemoterapia, 2006
La fisiopatogenia de las citopenias aloinmunes neonatales transita por 3 estadoos básicos: la aloinmunización materna, el paso trasplacentario de anticuerpos maternos al feto y la destrucción de las células sanguíneas fetales sensibilizadas.
María Elena Alfonso Valdés
doaj  

Ibrutinib and standard immunochemotherapy in younger, high‐risk patients with diffuse large B‐cell lymphoma: A phase II study of GLA

British Journal of Haematology, EarlyView.
Summary Younger patients with high‐risk diffuse large B‐cell lymphoma (DLBCL) frequently have unfavourable outcomes. We conducted a prospective phase II study evaluating ibrutinib plus rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone (R‐CHOEP+I) in patients aged 18–60 years with DLBCL and age‐adjusted international prognostic index ≥2.
Evgenii Shumilov, Marita Ziepert, Birte Friedrichs, Susanne Ghandili, Kai Wille, Bertram Glass, Maike Nickelsen, Peter Borchmann, Andreas Viardot, Andrea Kerkhoff, Philipp Berning, Sebastian Böttcher, Stefan Wirths, Tobias Kewitz, Mathias Hänel, Judith Dierlamm, Andreas Rosenwald, Bettina Altmann, Georg Lenz, Norbert Schmitz   +19 more
wiley   +1 more source

Assessing potential risk factors for metamizole-induced leukopenia

Background: Metamizole is a non-opioid analgesic agent that can rarely cause agranulocytosis, a severe form of leukopenia. Objectives: The aim of this study was to assess previously identified potential risk factors for the development of metamizole ...
Sarah Sonderer, Andreas Holboro, Birgit Brüne, Anne B. Leuppi-Taegtmeyer, Selina Späni, Kanchan Dongre, Jörg D. Leuppi, Simona Hübner, Maria Bösing   +8 more
core   +1 more source

Does chemotherapy-induced leukopenia predict a response in small cell lung cancer?

, 1998
The correlation between chemotherapy-induced toxicity and treatment outcome in cancer patients has not been studied thoroughly. Our aim was to evaluate whether there is any relationship between chemotherapy-induced leukopenia and response to treatment in
J. Jassem, K. Krawczyk, B.A. Jereczek-Fossa, H. Karnicka Mlodkowska, E. Kowal, K. Malak, R. Mos Antkowiak, E. Radzikowska, A. Badzio, A. Pilarska Machowicz, Pilarska-Machowicz, Anna, Moś-Antkowiak, Renata, Jassem, Jacek, Krawczyk, Kazimierz, Jereczek-Fossa, Barbara, Badzio, Andrzej, Kowal, Edmund, Malak, Kazimiera, Karnicka-Młodkowska, Hanna, Radzikowska, Elz˚bieta   +19 more
core   +1 more source

Phase II Study of Cisplatin/Gemcitabine Plus Necitumumab for Squamous NSCLC After ICI‐Platinum Therapy (WJOG14120L)

Cancer Science, EarlyView.
WJOG14120L NESSIE evaluated cisplatin, gemcitabine, and necitumumab (CGN) as second‐line therapy after ICI‐based treatment in 46 patients with advanced squamous NSCLC. ORR was 26.1%, DCR 87.0%, and median PFS 4.4 months. Although the predefined ORR threshold was not met, CGN showed modest antitumor activity with manageable toxicity.
Hiroshige Yoshioka, Keita Mori, Nobuhisa Ishikawa, Hiroaki Kanemura, Koichi Azuma, Yukihiro Toi, Hiroshi Handa, Yosuke Tamura, Hiroaki Akamatsu, Haruko Daga, Masafumi Yamaguchi, Teppei Yamaguchi, Yuki Sato, Nobuyuki Yamamoto, Kazuhiko Nakagawa, Takayasu Kurata   +15 more
wiley   +1 more source

Efek Samping Pengobatan Tuberkulosis Resistan Obat Terhadap Kejadian Leukopenia Pasien di RSUD Dr. Saiful Anwar Malang

, 2023
Tuberkulosis resistan obat merupakan penyakit disebabkan oleh bakteri Mycobacterium tuberculosis yang resistan terhadap obat anti tuberkulosis. Terjadinya resistansi dipengaruhi oleh beberapa faktor seperti kekebalan alami yang dimiliki bakteri ...
dr. Ungky Agus Setyawan, Sp. P(K), Ariesandi, Bima Gumilang, dr. Rezki Tantular, Sp.P(K)   +2 more
core  

Primary Cutaneous Gamma‐Delta T‐Cell Lymphoma Complicating Long‐Standing Immunosuppressed Dermatomyositis

Journal of Cutaneous Pathology, EarlyView.
ABSTRACT Primary cutaneous gamma‐delta T‐cell lymphoma (PCGD‐TCL) is a rare cytotoxic lymphoma with key oncogenic drivers in the JAK/STAT pathway. Also primarily involving the subcutaneous adipose tissue, subcutaneous panniculitis‐like T‐cell lymphoma (SPTCL) is more frequently encountered in scenarios of autoimmune disorders.
Bennett Christie‐Nguyen, Youn H. Kim, David F. Fiorentino, Danielle Tartar, Ryanne Brown, Robert A. Novoa, Kerri E. Rieger   +6 more
wiley   +1 more source

Laboratory manifestations of fetal inflammatory response syndrome in extremely premature newborns

Репродуктивная эндокринология
Background. Fetal inflammatory response syndrome (FIRS) is a pathological response to changes in the chorion and is manifested by inadequate cytokine production and endothelial dysfunction.
V.V. Bila
doaj   +1 more source